Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Before investing in cryptocurrency, it's important to be informed. Discover key insights that every investor should know.
18,573 articlesIovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
CrowdStrike delivered a strong quarter, beating earnings and lifting full-year guidance, and even announced a 4-for-1...
SpaceX's post-IPO moves could ripple through the market. This guide explains what to watch, how to react, and smart s...
Bitcoin remains perched above the 64,000 level as geopolitical tensions ease and investors reassess risk. This guide ...
Turning 55 can spark worries about retirement savings. This guide shows you practical steps to catch up, with real-wo...
Tilray’s stock has fallen dramatically this year. This in-depth guide breaks down what’s driving the drop, whether th...
Gas prices could push toward $4 a gallon again as a new IRS rule expands the gas expense deduction. The change target...
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
Two popular short-term bond ETFs—VCSH and ISTB—offer different paths to steady income. This guide breaks down cost, r...
This oddity tech stock is making waves again. With a larger share repurchase plan and improving cash flow, the stock ...
Curious about SoundHound AI's future? This in-depth guide lays out five-year scenarios, key drivers, and concrete tip...
Axsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...